The Dial Corporation Report issue

For profit Phase 2
Founded: Stamford CT United States (1948)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2008
NCT00762476
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

3804-250a (2 trials)

3804-291 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Common Cold (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2